ArticleBiomolecules2023

Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression.

Benjamin W Schlichtmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.